« Previous
Next »
Fertility and Sterility
Volume 93, Issue 2
, Pages 598-604
, 15 January 2010
“Physiologic ICSI”: Hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality
References
- . Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. Fertil Steril. 2003;79(Suppl 3):1616–1624
- Biochemical markers of sperm function: male fertility and sperm selection for ICSI. Reprod Biomed Online. 2003;7:462–468
- Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects. Reprod Biomed Online. 2007;14:650–663
- Intracytoplasmic sperm injection: a novel selection method for sperm with normal frequency of chromosomal aneuploidies. Fertil Steril. 2005;84:1665–1673
- . Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF and ICSI: systematic review and meta-analysis. Hum Reprod. 2008;23:2663–2668
- . The effect of legislation on outcomes of assisted reproduction technology: lessons from the 2004 Italian law. Fertil Steril. 2008;89:854–859
- . Laboratory techniques: sperm preparation for assisted conception. In: Brindsen P editors. In vitro fertilization and assisted reproduction. 2nd ed. New York: Parthenon; 1999;p. 206
- High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod. 1993;8:1061–1066
- . The sperm chromatin dispersion test: a simple method for the determination of sperm DNA fragmentation. J Androl. 2003;24:59–66
- The morphological normalcy of the sperm nucleus and pregnancy rate of intracytoplasmic injection with morphologically selected sperm. Hum Reprod. 2005;20:185–190
- . Improved diagnosis of male fertility potential via a combination of quantitative ultramorphology and routine semen analysis. Hum Reprod. 1994;9:2069–2075
- . Real-time fine morphology of motile human sperm cells is associated with IVF-ICSI outcome. J Androl. 2002;23:1–8
- . Roles and novel regimens of luteinizing hormone and follicle-stimulating homone in ovulation induction. J Clin Endocrin Metab. 2001;86:1437–1441
- . Oocyte morphology does not correlate with fertilization rate and embryo quality after intracytoplasmic sperm injection. Hum Reprod. 1999;11:595–597
- . Intracytoplasmic sperm injection: correlation of oocyte grade based polar body, perivitelline space and cytoplasmic inclusion with fertilization rate and embryo quality. Hum Reprod. 1997;12:1750–1755
- . Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review. Hum Reprod Update. 2003;9:251–262
- . Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod. 2000;15:427–430
- . Preembryo grading and degree of cytoplasmic fragmentation. In: Veeck LL editors. An atlas of human gametes and conceptuses. New York: Parthenon; 1999;p. 40–45
- . A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J Vitro Fert Embryo Transfer. 1986;3:284–295
- . Laboratory manual for the examination of human semen and sperm–cervical mucus interaction. 3rd ed.. Cambridge, UK: Cambridge University; 1992;
- Sperm selection for ICSI: shape properties do not predict the absence of numerical chromosomal aberrations. Hum Reprod. 2004;19:1052–1059
- Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod. 2002;17:2600–2614
- . Follow-up of children born after ICSI. Hum Reprod Update. 2002;8:111–116
- . Intracytoplasmic sperm injection without polyvinylpyrrolidone: an essential precaution?. Hum Reprod. 1996;11:2332
- . Intracytoplasmic sperm injection with polyvinylpyrrolidone: a potential risk. Fertil Steril. 2001;76:419–420
- Detrimental effects of polyvinylpyrrolidone on the ultrastructure of spermatozoa (Notulae seminologicae 13). Hum Reprod. 1998;13:120–123
- . An alternative to PVP for slowing sperm prior to ICSI. Hum Reprod. 2003;18:1887–1889
- . A physiological replacement for polyvinylpyrrolidone (PVP) in assisted reproductive technology. Hum Fertil (Camb). 2001;4:99–103
- . Persistent histones in immature sperm are associated with DNA fragmentation and affect paternal contribution of sperm: a study of aniline blue staining, fluorescence in situ hybridization (FISH) and DNA nick translation. Fertil Steril. 2004;82(Supp 2):S52
- . Nuclear chromatin variations in human spermatozoa undergoing swim-up and cryopreservation evaluated by the flow cytometric sperm chromatin structure assay. Mol Hum Reprod. 1999;5:29–37
- . Comparison of chromatin assays for DNA fragmentation evaluation in human sperm. J Androl. 2006;27:53–59
- . Evaluation of sperm selection procedure based on hyaluronic acid binding ability on ICSI outcome. J Assist Reprod Genet. 2008;25:197–203
- Pregnancy rates are higher with intracytoplasmic morphologically selected sperm injection than with conventional intracytoplasmic injection. Fertil Steril. 2003;80:1413–1419
- Intracytoplasmic morphologically selected sperm injection: a prospective randomized trial. Reprod Biomed Online. 2008;16:835–841
- . High-magnification ICSI overcomes paternal effect resistant to conventional ICSI. Reprod Biomed Online. 2006;12:19–25
- . The morphological normalcy of the sperm nucleus and pregnancy rate of intracytoplasmic injection with morphologically selected sperm. Hum Reprod. 2005;20:185–190
- . Replacement of PVP by hyaluronate (SpermSlow) in ICSI—impact on outcome. Eighteenth World Congress on Fertility and Sterility, International Federation of Fertility Societies. 2004;
- . PICSI vs ICSI: statistically significant improvement in clinical outcomes in 240 in vitro fertilization (IVF) patients. Fertil Steril. 2007;88(Supp 1):s37
- . Preliminary clinical and FISH results on hyaluronic acid sperm selection to improve ICSI. Hum Reprod. 2005;20(Supp 1):i200
L.P. has nothing to disclose. G.E.C. has nothing to disclose. S.B. has nothing to disclose. E.T. has nothing to disclose. W.C. has nothing to disclose. M.F. has nothing to disclose.
PII: S0015-0282(09)00598-6
doi: 10.1016/j.fertnstert.2009.03.033
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 93, Issue 2
, Pages 598-604
, 15 January 2010

